A Retrospective Study With Prospective Follow-Up of Laparoscopic Ventral Hernia Repair Utilizing the Bard Sepramesh IP Composite

C. R. Bard

Status: Completed

Conditions: Hernia

Study type: Observational

Funder types: Industry

Identifiers

NCT01305473

DVL-HE007

Details and patient eligibility

About

This study will enroll subjects who underwent a laparoscopic ventral hernia repair utilizing Sepramesh at least 12 months before starting in this study.

The consented subjects' medical records will be reviewed for evidence of any risk factors of hernia recurrence, procedure time, complications and any documented recurrences. The subjects will be asked to undergo a physical exam to rule out any recurrences that were not documented in the medical records.

Enrollment: 90 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have undergone a laparoscopic ventral repair utilizing Sepramesh at least 12 months before starting in this study.
• Have signed an Informed Consent Form (ICF).

Exclusion criteria

• Underwent implantation of Sepramesh for any reason other than ventral hernia repair.

Trial design

90 participants in 1 patient group

Sepramesh Group